These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 3322235)
21. Preferential selection of receptor-binding variants of influenza virus hemagglutinin by the neutralizing antibody repertoire of transgenic mice expressing a human immunoglobulin mu minigene. Laeeq S; Smith CA; Wagner SD; Thomas DB J Virol; 1997 Apr; 71(4):2600-5. PubMed ID: 9060611 [TBL] [Abstract][Full Text] [Related]
22. Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. IV. Immunogenic properties of separated haemagglutinin glycopolypeptides. Styk B; Russ G; Poláková K Acta Virol; 1979 Jan; 23(1):9-20. PubMed ID: 35964 [TBL] [Abstract][Full Text] [Related]
24. Broadly cross-reactive monoclonal antibodies against HA2 glycopeptide of Influenza A virus hemagglutinin of H3 subtype reduce replication of influenza A viruses of human and avian origin. Stropkovská A; Mucha V; Fislová T; Gocník M; Kostolanský F; Varecková E Acta Virol; 2009; 53(1):15-20. PubMed ID: 19301946 [TBL] [Abstract][Full Text] [Related]
25. Protection of mice against lethal viral infection by synthetic peptides corresponding to B- and T-cell recognition sites of influenza A hemagglutinin. Simeckova-Rosenberg J; Yun Z; Wyde PR; Atassi MZ Vaccine; 1995 Jul; 13(10):927-32. PubMed ID: 7483766 [TBL] [Abstract][Full Text] [Related]
26. Characterization of host cell binding variants of influenza virus by monoclonal antibodies. Nohinek B; Gerhard W; Schulze IT Virology; 1985 Jun; 143(2):651-6. PubMed ID: 2414912 [TBL] [Abstract][Full Text] [Related]
27. [Monoreceptor antibodies to the hemagglutinin antigenic determinants of influenza viruses H2N2 and their virus-neutralizing activity]. Ismaĭlova IM; Isaeva EI; Rovnova ZI Vopr Virusol; 1985; 30(1):115-9. PubMed ID: 2581366 [No Abstract] [Full Text] [Related]
28. Antigenic analysis of recent H1N1 influenza viruses with monoclonal antibodies. Yamada A; Cao MS; Imanishi J; Oyama S; Abe A; Katagiri S Acta Virol; 1991 Aug; 35(4):343-9. PubMed ID: 1724874 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of influenza virus haemolytic and haemagglutination activities by monoclonal antibodies to haemagglutinin glycopolypeptides HA1 and HA2. Kostolanský F; Styk B; Russ G Acta Virol; 1989 Dec; 33(6):504-12. PubMed ID: 2576592 [TBL] [Abstract][Full Text] [Related]
30. A single amino acid substitution in influenza hemagglutinin abrogates recognition by monoclonal antibody and a spectrum of subtype-specific L3T4+ T cell clones. Thomas DB; Skehel JJ; Mills KH; Graham CM Eur J Immunol; 1987 Jan; 17(1):133-6. PubMed ID: 2434337 [TBL] [Abstract][Full Text] [Related]
31. Immunogenic structure of the influenza virus hemagglutinin. Green N; Alexander H; Olson A; Alexander S; Shinnick TM; Sutcliffe JG; Lerner RA Cell; 1982 Mar; 28(3):477-87. PubMed ID: 6176330 [TBL] [Abstract][Full Text] [Related]
32. Antibodies to the strain-specific and cross-reactive determinants of the haemagglutinin of influenza H3N2 viruses. 1. Preparation of antibodies and in vitro studies. Haaheim LR; Schild GC Acta Pathol Microbiol Scand B; 1979 Oct; 87(5):291-9. PubMed ID: 93399 [TBL] [Abstract][Full Text] [Related]
33. Enzyme immunoassay, complement fixation and hemagglutination inhibition tests in the diagnosis of influenza A and B virus infections. Purified hemagglutinin in subtype-specific diagnosis. Julkunen I; Pyhälä R; Hovi T J Virol Methods; 1985 Jan; 10(1):75-84. PubMed ID: 3882733 [TBL] [Abstract][Full Text] [Related]
34. Dissociation of the haemagglutination inhibition and the infectivity neutralization in the reactions of influenza A/USSR/90/77 (H1N1) virus variants with monoclonal antibodies. Gitelman AK; Kaverin NV; Kharitonenkov IG; Rudneva IA; Sklyanskaya EL; Zhdanov VM J Gen Virol; 1986 Oct; 67 ( Pt 10)():2247-51. PubMed ID: 3760825 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of the subtype specificity of monoclonal antibodies raised against H1 and H3 subtypes of human influenza A virus hemagglutinins. Varecková E; Cox N; Klimov A J Clin Microbiol; 2002 Jun; 40(6):2220-3. PubMed ID: 12037091 [TBL] [Abstract][Full Text] [Related]
36. Characterization of H2 influenza virus hemagglutinin with monoclonal antibodies: influence of receptor specificity. Yamada A; Brown LE; Webster RG Virology; 1984 Oct; 138(2):276-86. PubMed ID: 6208682 [TBL] [Abstract][Full Text] [Related]
37. Heterosubtypic protection against influenza A induced by adenylate cyclase toxoids delivering conserved HA2 subunit of hemagglutinin. Staneková Z; Adkins I; Kosová M; Janulíková J; Sebo P; Varečková E Antiviral Res; 2013 Jan; 97(1):24-35. PubMed ID: 23036818 [TBL] [Abstract][Full Text] [Related]
38. Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies. Mazanec MB; Coudret CL; Fletcher DR J Virol; 1995 Feb; 69(2):1339-43. PubMed ID: 7815518 [TBL] [Abstract][Full Text] [Related]
39. Use of monoclonal antibodies for rapid detection of influenza A virus in nasopharyngeal secretions. Pothier P; Denoyel GA; Ghim S; Prudhomme de Saint Maur G; Freymuth F Eur J Clin Microbiol; 1986 Jun; 5(3):336-9. PubMed ID: 3527703 [TBL] [Abstract][Full Text] [Related]
40. An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin. Brown LE; Murray JM; White DO; Jackson DC Arch Virol; 1990; 114(1-2):1-26. PubMed ID: 1699509 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]